OPEN END TURBO PUT WARRANT - AMGEN | Market Closed - Deutsche Boerse AG 18:33:25 25/06/2024 BST | ||
| 0.41 EUR | -10.87% |
|
| Current month | -24.07% | ||
| 1 month | -21.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 0.41 | -10.87% |
| 24/06/24 | 0.46 | -9.80% |
| 21/06/24 | 0.51 | -1.92% |
| 20/06/24 | 0.52 | +4.00% |
| 19/06/24 | 0.5 | -9.09% |
Delayed Quote Deutsche Boerse AG
Last update June 25, 2024 at 06:33 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UK8X5P |
| ISIN | DE000UK8X5P3 |
| Date issued | 28/10/2022 |
| Strike | 363.8 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 1.14 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.48 € |
|---|---|
| Lowest since issue | 0.37 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
